There has been a significant shift in the fundamentals for Cg Oncology Inc. (NASDAQ:CGON)

Cg Oncology Inc. (NASDAQ:CGON) shares traded 0.47% higher at $33.89 on Wall Street last session.

CGON stock price is now -2.20% away from the 50-day moving average and -10.07% away from the 200-day moving average. The market capitalization of the company currently stands at $2.26B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target of $55, Morgan Stanley recently initiated with Overweight rating for Cg Oncology Inc. (NASDAQ: CGON). On February 20, 2024, Goldman recently initiated its ‘Neutral’ rating on the stock quoting a target price of $42, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’

In other news, Decheng Capital Global Life Sc, 10% Owner bought 400,000 shares of the company’s stock on Jan 29 ’24. The stock was bought for $7,600,000 at an average price of $19.00. Upon completion of the transaction, the 10% Owner now directly owns 400,000 shares in the company, valued at $13.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 29 ’24, Director Song Hong Fang bought 263,157 shares of the business’s stock. A total of $4,999,983 was incurred on buying the stock at an average price of $19.00. This leaves the insider owning 613,928 shares of the company worth $20.81 million. A total of 38.90% of the company’s stock is owned by insiders.

During the past 12 months, Cg Oncology Inc. has had a low of $25.77 and a high of $50.23. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 57.95, and a quick ratio of 57.95. The fifty day moving average price for CGON is $34.5486 and a two-hundred day moving average price translates $37.646137 for the stock.

The latest earnings results from Cg Oncology Inc. (NASDAQ: CGON) was released for 2024-03-31.

Related Posts